Operator of a bio-pharmaceutical company. The company is focused on the development of in vitro culture systems for the malaria parasite which will lead to the development of an effective whole-parasite vaccine.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Early Stage VC | 21-Jun-2017 | $1.05M | 00.00 | Completed | Startup | |
1. Angel (individual) | 23-Nov-2015 | 00000 | 00000 | Completed | Startup |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
James Davie | Co-Founder, President & Chief Executive Officer | ||
Paul Harris Ph.D | Co-Founder & Vice President, Product Development |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Keiretsu Forum | Venture Capital | Minority | 000 0000 | 000000 0 |